VADACCA, MARTA
 Distribuzione geografica
Continente #
AS - Asia 1.556
NA - Nord America 117
EU - Europa 80
SA - Sud America 7
AF - Africa 1
OC - Oceania 1
Totale 1.762
Nazione #
SG - Singapore 1.468
US - Stati Uniti d'America 116
CN - Cina 46
HK - Hong Kong 37
IT - Italia 28
GB - Regno Unito 20
NL - Olanda 10
BR - Brasile 7
DE - Germania 7
FI - Finlandia 4
CZ - Repubblica Ceca 3
FR - Francia 3
IN - India 2
PL - Polonia 2
AU - Australia 1
ES - Italia 1
JP - Giappone 1
LU - Lussemburgo 1
MX - Messico 1
SA - Arabia Saudita 1
TR - Turchia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 1.762
Città #
Hong Kong 37
Ashburn 34
Singapore 32
Hefei 22
Boardman 21
London 19
Rome 16
Shanghai 14
Council Bluffs 10
Amsterdam 9
Jaguariúna 7
Los Angeles 6
San Francisco 4
Washington 4
Brno 3
Naples 3
Brooklyn 2
Charlotte 2
Guangzhou 2
Helsinki 2
Munich 2
New York 2
Pune 2
Turku 2
Warsaw 2
West Jordan 2
Xingtai 2
Canberra 1
Chicago 1
Cleveland 1
Frankfurt am Main 1
Handan 1
Las Vegas 1
Lecce 1
Luxembourg 1
Manchester 1
Mexico City 1
Montpellier 1
Newark 1
Philadelphia 1
Riyadh 1
San Diego 1
Santa Clara 1
Schaumburg 1
Shenzhen 1
Sona 1
The Dalles 1
Tokyo 1
Totale 284
Nome #
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 163
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 153
Relationship between leptin and regulatory T cells in systemic lupus erythematosus: preliminary results 146
Leptin in immuno-rheumatological diseases 140
Ii-key/insulin MHC class-II antigenic epitope peptides in type 1 diabetes 135
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 130
Detection of T cell response to insulin and GAD in Type 1 diabetes using the Ii-Key-hybrid technique 129
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 118
Ii-key/MHC class II epitope hybrid technology to detect T cell response to insulin and GAD in type 1 diabetes. 78
Identification of a new method to detect t cell response in type 1 diabetes 67
A novel approach to study T cell response to Ii-KEY/MHC class II epitope hybrid peptides in type 1 diabetes 62
Ii-key/MHC class II epitope hybrid technology and ELISPOT as say in type 1 diabetes 61
Leptin in autoimmune mechanisms of systemic rheumatic diseases 61
Real-life survey on severe asthma patients during COVID-19 lockdown in Italy 53
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 49
Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology 46
Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential 45
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 39
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 38
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 30
The IL33/ST2 axis in Sjogren syndrome in relation to disease activity 19
The similar expression of both ferritin and scavenger receptors activation genes in patients with COVID19 and AOSD support their role in the pathogenesis of these diseases and identify a common mechanism at the basis of the "hyperferritinemic syndromes" 17
The Relationship Between Metabolic Syndrome and Pain Catastrophizing in Psoriatic Arthritis 2
Totale 1.781
Categoria #
all - tutte 7.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.576


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202219 0 0 0 0 0 0 0 0 2 1 0 16
2022/202334 1 4 0 0 16 0 1 0 1 0 11 0
2023/202478 1 8 6 4 8 32 0 0 2 3 7 7
2024/20251.650 15 4 22 10 10 24 10 3 71 119 777 585
Totale 1.781